BTIG Research Issues Positive Forecast for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQYFree Report) had its price target hoisted by BTIG Research from $110.00 to $130.00 in a research report released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

HQY has been the topic of several other reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. JMP Securities restated a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Bank of America upped their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Barrington Research reissued an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $107.23.

Check Out Our Latest Report on HQY

HealthEquity Trading Up 3.4 %

Shares of HQY opened at $98.98 on Thursday. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.64 billion, a PE ratio of 82.48, a PEG ratio of 1.55 and a beta of 0.52. HealthEquity has a 1 year low of $62.10 and a 1 year high of $101.17. The stock has a 50 day simple moving average of $85.02 and a 200-day simple moving average of $81.09.

HealthEquity (NASDAQ:HQYGet Free Report) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. On average, sell-side analysts predict that HealthEquity will post 2.27 EPS for the current fiscal year.

Insider Activity at HealthEquity

In related news, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock worth $884,517 in the last quarter. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

A number of institutional investors have recently modified their holdings of the company. Geode Capital Management LLC raised its position in HealthEquity by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock valued at $170,197,000 after buying an additional 15,145 shares during the last quarter. M&T Bank Corp boosted its position in HealthEquity by 0.7% during the 3rd quarter. M&T Bank Corp now owns 49,447 shares of the company’s stock worth $4,047,000 after acquiring an additional 321 shares during the last quarter. Barclays PLC grew its stake in shares of HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock worth $13,628,000 after acquiring an additional 112,667 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of HealthEquity by 5.6% in the third quarter. Public Employees Retirement System of Ohio now owns 91,754 shares of the company’s stock valued at $7,510,000 after purchasing an additional 4,878 shares during the last quarter. Finally, Main Management ETF Advisors LLC bought a new stake in shares of HealthEquity in the third quarter worth $889,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.